Phibro Animal Health Co. (NASDAQ:PAHC) Shares Acquired by American Century Companies Inc.

American Century Companies Inc. boosted its position in Phibro Animal Health Co. (NASDAQ:PAHC) by 18.0% in the 4th quarter, HoldingsChannel reports. The firm owned 635,599 shares of the company’s stock after purchasing an additional 96,787 shares during the period. American Century Companies Inc.’s holdings in Phibro Animal Health were worth $13,348,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Geode Capital Management LLC raised its position in shares of Phibro Animal Health by 5.7% in the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock valued at $11,430,000 after buying an additional 27,201 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of Phibro Animal Health by 8.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 290,656 shares of the company’s stock worth $6,104,000 after purchasing an additional 22,263 shares during the period. Bank of New York Mellon Corp boosted its holdings in shares of Phibro Animal Health by 2.9% during the fourth quarter. Bank of New York Mellon Corp now owns 272,632 shares of the company’s stock worth $5,725,000 after purchasing an additional 7,747 shares during the last quarter. Globeflex Capital L P grew its position in shares of Phibro Animal Health by 0.8% in the fourth quarter. Globeflex Capital L P now owns 206,595 shares of the company’s stock valued at $4,338,000 after purchasing an additional 1,700 shares during the period. Finally, Jacobs Levy Equity Management Inc. increased its stake in Phibro Animal Health by 116.6% in the third quarter. Jacobs Levy Equity Management Inc. now owns 192,255 shares of the company’s stock valued at $4,330,000 after purchasing an additional 103,491 shares during the last quarter. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Stock Performance

NASDAQ PAHC opened at $21.97 on Wednesday. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. Phibro Animal Health Co. has a 1-year low of $12.17 and a 1-year high of $26.55. The firm has a market capitalization of $889.85 million, a P/E ratio of 45.77, a P/E/G ratio of 0.45 and a beta of 0.58. The business’s 50-day simple moving average is $22.80 and its 200-day simple moving average is $22.69.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. Equities analysts predict that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Wednesday, March 5th were issued a $0.12 dividend. The ex-dividend date of this dividend was Wednesday, March 5th. This represents a $0.48 annualized dividend and a yield of 2.18%. Phibro Animal Health’s dividend payout ratio is currently 100.00%.

Analysts Set New Price Targets

PAHC has been the topic of a number of research analyst reports. Morgan Stanley raised their price target on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Barclays raised their target price on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research report on Monday, February 10th. Finally, StockNews.com lowered shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research report on Tuesday, March 25th. Two equities research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $21.00.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.